"What's new" in Alzheimer's disease
medical treatments and diagnosis is the focus of the first day's plenary
sessions at the 25th International Conference of Alzheimer's Disease
International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki,
Greece.
Sam Gandy, M.D., Ph.D. of Mount Sinai Alzheimer's Disease Research
Center, New York, will address "New Treatment Developments" in Alzheimer's,
including therapies that have the greatest potential for entering clinical
practice in the next few years - bapineuzumab, latrepirdine, and gamma
secretase inhibitors. He also will touch on intriguing science that may
explain the link between Alzheimer's and diabetes.